| Name | Title | Contact Details |
|---|
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
Welsh Home is a Rocky River, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OneLegacy is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ENABLE Healthcare Communications is a Herndon, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Norwegian American Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Chicago, IL. To find more information about Norwegian American Hospital, please visit www.nahospital.org